中国中医科学院广安门医院,北京市西城区广安门内大街北线阁5号,100053
通讯作者:doctorjq@126.com
收稿:2025-11-17,
修回:2025-12-18,
录用:2026-01-27,
纸质出版:2026-06-02
移动端阅览
姜春云,姜泉,王建等.中医证型与类风湿关节炎相关动脉粥样硬化事件的关联性分析——一项多中心横断面研究[J].中医杂志,2026,67(11):1192-1199.
JIANG Chunyun,JIANG Quan,WANG Jian,et al.Correlation Between Traditional Chinese Medicine Syndromes and Rheumatoid Arthritis with Atherosclerosis:A Multicenter Cross-Sectional Study[J].Journal of Traditional Chinese Medicine,2026,67(11):1192-1199.
姜春云,姜泉,王建等.中医证型与类风湿关节炎相关动脉粥样硬化事件的关联性分析——一项多中心横断面研究[J].中医杂志,2026,67(11):1192-1199. DOI: 10.13288/j.11-2166/r.2026.11.011.
JIANG Chunyun,JIANG Quan,WANG Jian,et al.Correlation Between Traditional Chinese Medicine Syndromes and Rheumatoid Arthritis with Atherosclerosis:A Multicenter Cross-Sectional Study[J].Journal of Traditional Chinese Medicine,2026,67(11):1192-1199. DOI: 10.13288/j.11-2166/r.2026.11.011.
目的
2
探讨类风湿关节炎(RA)患者发生动脉粥样硬化(AS)的影响因素及与中医证型的相关性。
方法
2
采用横断面研究方法,纳入全国122家医疗中心的16 082例RA患者。通过问卷调查记录患者一般资料、病情评估资料[包括28个关节疾病活动度(DAS-28)、压痛关节数(TJC)、肿胀关节数(SJC)、患者疾病评估分数(PGA)、医生疾病评估分数(EGA)、视觉模拟评分(VAS)]、主要临症状程度(包括失眠、食欲、心烦不安、疲乏)、实验室指标(包括血常规、炎症指标、肝功能、肾功能、代谢指标、凝血指标)等。根据四诊信息将患者分为风湿痹阻证、寒湿痹阻证、湿热痹阻证、痰瘀痹阻证、瘀血阻络证、气血两虚证、肝肾不足证、气阴两虚证8种证型。将发生AS事件的患者纳入事件组(564例),未发生AS事件的患者纳入非事件组(15 518例)。采用组间差异性检验筛选潜在相关因素,并通过二元Logistic回归分析中医证型与类风湿关节炎相关动脉粥样硬化(RA-AS)的相关性。
结果
2
与非事件组比较,事件组患者病程、体重、年龄较高(
P
<0.05),且DAS-28、TJC、SJC、PGA、EGA、VAS、红细胞沉降率(ESR)、低密度脂蛋白胆固醇(LDL-C)、甘油三酯(TG)、总胆固醇(TC)、D-二聚体(D-Dimer)水平明显升高,高密度脂蛋白胆固醇(HDL-C)降低,失眠、心烦不安、疲乏症状严重(
P
<0.05)。两组的主要证型均为湿热痹阻证,事件组中占比为69.68%(393/564),高于非事件组的29.50%(4578/15 518,
P
<0.05)。Logistic回归显示,湿热痹阻证患者发生RA-AS的风险是非湿热痹阻证的5.326倍[
OR=
5.326,95%
CI
(4.517~7.089),
P
<0.001]。
结论
2
RA-AS的发生与中医证型、疾病活动度、炎症及血脂代谢指标均存在关联,其中湿热痹阻证是RA-AS事件的独立危险因素。
Objective
2
To investigate the risk factors for atherosclerosis (AS) in rheumatoid arthritis (RA) patients and its correlation with traditional Chinese medicine (TCM) syndromes.
Methods
2
A cross-sectional study was conducted, enrolling 16
082 RA patients from 122 medical centers nationwide. Patient demographics, disease assessment data including disease activity (DAS-28), tender joint count (TJC), swollen joint count (SJC), patient's global assessment (PGA), evaluator's global assessment (EGA), and visual analogue scale (VAS), major clinical symptoms including insomnia, loss of appetite, irritability, and fatigue, and laboratory indicators including blood routine
, inflammatory markers, liver and kidney function, metabolic indices, and coagulation markers were collected through questionnaire. Based on the four examinations in TCM, patients were classified into eight TCM syndromes, which were wind-damp obstruction, cold-damp obstruction, damp-heat obstruction, phlegm-stasis obstruction, blood stasis obstructing the collaterals,
qi
-blood deficiency, liver-kidney insufficiency, and
qi
-
yin
deficiency. Patients who experienced AS events were included in the event group (564 cases), while those without AS events were included in the non-event group (15
518 cases). Intergroup difference tests were used to screen potential risk factors, and binary logistic regression analysis was employed to assess the correlation between TCM syndromes and rheumatoid arthritis with atherosclerosis (RA-AS).
Results
2
Compared to the non-event group, patients in the event group had longer disease duration, higher body weight, and older age (
P
<0.05), and showed significantly higher DAS28, TJC, SJC, PGA, EGA, VAS, ESR, low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), total cholesterol (TC), and D-dimer levels, and lower high-density lipoprotein cholesterol (HDL-C), with more severe symptoms of insomnia, irritability, and fatigue (
P
<0.05). Damp-heat obstruction syndrome was the most prevalent in both groups, with a higher proportion in the event group (393/564, 69.68%) than in the non-event group (4578/15
518, 29.50%) showing significant difference (
P
<0.05). Logistic regression analysis showed that patients with damp-heat obstruction syndrome had a 5.326-fold higher risk of developing RA-AS compared to those without this syndrome (
OR
=5.326, 95%
CI
4.517 to 7.089,
P
<0.001).
Conclusion
2
The occurrence of RA-AS is associated with TCM syndromes, disease activity, inflammatory markers and lipid metabolic indices, and damp-heat obstruction syndrome is an independent risk factor for RA-AS.
KATZ J , BARTELS C M . Multimorbidity in rheumatoid arthritis: literature review and future directions [J]. Curr Rheumatol Rep , 2024 , 26 ( 1 ): 24 - 35 .
KEROLA A M , KEROLA T , KAUPPI M J , et al . Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis [J]. Ann Rheum Dis , 2013 , 72 ( 11 ): 1826 - 1829 .
GONG X , LIU W X , JIANG Q , et al . China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): rationale, design, and baseline characteristics of the first 11 764 enrollees [J]. Phytomedicine , 2022 , 104 : 154236 . doi: 10.1016/j.phymed.2022. 154236 http://dx.doi.org/10.1016/j.phymed.2022.154236 .
ALETAHA D , NEOGI T , SILMAN A J , et al . 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative [J]. Arthritis Rheum , 2010 , 62 ( 9 ): 2569 - 2581 .
VIRANI S S , NEWBY L K , ARNOLD S V , et al . 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines [J]. Circulation , 2023 , 148 ( 9 ): e9 - e119 .
中华中医药学会《类风湿关节炎病证结合诊疗指南》项目组 . 类风湿关节炎病证结合诊疗指南(2025年) [J]. 中医杂志 , 2025 , 66 ( 17 ): 1842 - 1856 .
FELSON D , LACAILLE D , LAVALLEY M P , et al . Re-examining remission definitions in rheumatoid arthritis: considering the 28-joint disease activity score, C-reactive protein level and patient global assessment [J]. Ann Rheum Dis , 2022 , 81 ( 1 ): 4 - 7 .
CHEUNG P P , LAHIRI M , MARCH L , et al . Patient-reported outcomes in Asia: evaluation of the properties of the rheumatoid arthritis impact of disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis [J]. Clin Rheumatol , 2017 , 36 ( 5 ): 1149 - 1154 .
BERGLIN E , DAHLQVIST S R . Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study [J]. Scand J Rheumatol , 2013 , 42 ( 5 ): 362 - 368 .
DI MATTEO A , BATHON J M , EMERY P . Rheumatoid arthritis [J]. Lancet , 2023 , 402 ( 10416 ): 2019 - 2033 .
SMOLEN J S , ALETAHA D , MCINNES I B . Rheumatoid arthritis [J]. Lancet , 2016 , 388 ( 10055 ): 2023 - 2038 .
TONG X , SHEN C Y , JEON H L , et al . Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: a multi-centre cohort study [J]. J Intern Med , 2023 , 294 ( 3 ): 314 - 325 .
ZAMAN S , WASFY J H , KAPIL V , et al . The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma [J]. Lancet , 2025 , 405 ( 10 486 ): 1264 - 1312 .
李进 , 陈玉梅 . 从《素问·痹论篇》探讨痹证的治疗方法 [J]. 实用中医药杂志 , 2004 , 20 ( 12 ): 721 .
姜泉 . “体脏合痹”理论内涵及其在风湿免疫病防治中的应用思路 [J]. 中医杂志 , 2024 , 65 ( 16 ): 1656 - 1661 .
DEL RINCÓN I , FREEMAN G L , HAAS R W , et al . Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis [J]. Arthritis Rheum , 2005 , 52 ( 11 ): 3413 - 3423 .
CASTAÑEDA S , VICENTE-RABANEDA E F , GARCÍA-CASTAÑEDA N , et al . Unmet needs in the management of cardiovascular risk in inflammatory joint diseases [J]. Expert Rev Clin Immunol , 2020 , 16 ( 1 ): 23 - 36 .
CHARLES-SCHOEMAN C , BUCH M H , DOUGADOS M , et al . Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc ana-lysis from ORAL Surveillance [J]. Ann Rheum Dis , 2023 , 82 ( 1 ): 119 - 129 .
ENGLAND B R , THIELE G M , ANDERSON D R , et al . Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications [J]. BMJ , 2018 , 361 : k1036 . doi: 10.1136/bmj.k1036 http://dx.doi.org/10.1136/bmj.k1036 .
LIAO K P . Cardiovascular disease in patients with rheumatoid arthritis [J]. Trends Cardiovasc Med , 2017 , 27 ( 2 ): 136 - 140 .
AUSSERWINKLER M , GENSLUCKNER S , VOELKERER A , et al . Genetic relationship between rheumatoid arthritis and cardiovascular diseases: a systematic review of Mendelian randomization studies [J]. Wien Klin Wochenschr , 2025 , 137 ( 9/10 ): 272 - 278 .
DEBOSE-BOYD R A . Significance and regulation of lipid metabolism [J]. Semin Cell Dev Biol , 2018 , 81 : 97 . doi: 10.1016/j.semcdb.2017.12.003 http://dx.doi.org/10.1016/j.semcdb.2017.12.003 .
KARPOUZAS G A , PAPOTTI B , ORMSETH S R , et al . Changes in serum cholesterol loading capacity are linked to coronary atherosclerosis progression in rheumatoid arthritis [J]. RMD Open , 2024 , 10 ( 4 ): e004991 .
KASHER M , CHERNY S S , CHARGE Inflammation Working Group , et al . Exploring potential shared genetic influences between rheumatoid arthritis and blood lipid levels [J]. Atherosclerosis , 2022 , 363 : 48 - 56 . doi: 10. 1016/j.atherosclerosis.2022.11.006 http://dx.doi.org/10.1016/j.atherosclerosis.2022.11.006 .
MO X , GUO Y , QIAN Q , et al . Phosphorylation-related SNPs influence lipid levels and rheumatoid arthritis risk by altering gene expression and plasma protein levels [J]. Rheumatology (Oxford) , 2020 , 59 ( 4 ): 889 - 898 .
ZINELLU A , MANGONI A A . A systematic review and meta-analysis of the association between the D-dimer and rheumatic diseases [J]. Immun Inflamm Dis , 2024 , 12 ( 7 ): e1349 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号